4//SEC Filing
BLATT LAWRENCE 4
Accession 0001567619-22-002892
CIK 0001799448other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:09 PM ET
Size
7.8 KB
Accession
0001567619-22-002892
Insider Transaction Report
Form 4
BLATT LAWRENCE
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-04+80,850→ 80,850 totalExercise: $3.06Exp: 2032-02-04→ Common Stock (80,850 underlying) - Award
Stock Option (Right to Buy)
2022-02-04+323,400→ 323,400 totalExercise: $3.06Exp: 2032-02-04→ Common Stock (323,400 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- [F2]100% of the shares subject to the Option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through such vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001242110
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:09 PM ET
- Size
- 7.8 KB